ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

130
Analysis
Health CareIndia
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Refresh
bullishHilong Holding
23 Jun 2020 08:52

Morning Views Asia: Fosun International, Glenmark Pharmaceuticals, Modernland Realty, Softbank Group

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
281 Views
Share
21 Jun 2020 13:15

Glenmark Pharma: Approval for Covid-19 Oral Drug

In Unlock 1 Ill-Effects: Boon for the Consumer Discretionary? we highlighted the current covid 19 scenario where there is not a single trace of...

Logo
268 Views
Share
02 Jun 2020 15:56

Asia HY Monthly - Takeaways From China's Two Sessions (2020) - Lucror Analytics

From an investor’s perspective, the month of May was dominated by two issues: the likely rate of the post-pandemic economic recovery, and mounting...

Logo
329 Views
Share
28 May 2020 16:36

Asia HY Trade Recommendations - May 2020 - Lucror Analytics

The Asia HY Trade Recommendations report for the month of May includes a summary of our recommendations. The report also features relative-value...

Logo
285 Views
Share
22 May 2020 16:26

Thomson Medical Group: Medicated by Leverage

We initiate our coverage of Thomson Medical Group Limited (ROWS SP) (TMG). The acquisition of a profitable Thomson Medical Centre (TMC) together...

Logo
327 Views
Share
x